Robert Olaso

Commissariat à l'Énergie Atomique et aux Énergies Alternatives — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index9.5kcitations181works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Rare Diseases(33), Genetic Associations and Epidemiology(19), Genetics and Neurodevelopmental Disorders(13), Blood Coagulation and Thrombosis Mechanisms(12), Venous Thromboembolism Diagnosis and Management(11)

Publications175 total

Genomics of Long‐Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study
Pediatric Blood & Cancer·2026Open Access
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
EBioMedicine·2025Open Access
LEAP-InovAND a multiscale resource to explore genetics, brain imaging and clinical data in autism
2025· 1 citedOpen Access
Deep exploration of the TCR CDR3β repertoire specific for viral CD4 T-cell epitopes inside the circulating T-cell repertoire
Frontiers in Immunology·2025Open Access
Assessing the integrity of SARS-CoV-2 and F-specific RNA bacteriophage RNA in raw wastewater (ANRS0160)
Water Research·2025Open Access
PROK1 locus variant identified as a genetic determinant of anthracycline-related cardiomyopathy in long-term childhood acute leukemia survivors
Blood·2025Open Access
Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolism
2025Open Access
Genome sequencing for the diagnosis of intellectual disability as a paradigm for rare diseases in the French healthcare setting: the prospective DEFIDIAG study
Genome Medicine·2025· 1 citedOpen Access
Development and validation of a next-generation sequencing-based method for calculating the breast cancer polygenic risk score PRS313
The Breast·2025Open Access
Rare Variants Associated With Pediatric Cancer Treatment–Related Second Malignant Neoplasm Risk
JCO Precision Oncology·2025
Resolving structural variations missed by short-read sequencing uncovers their pathogenicity
Journal of Medical Genetics·2025· 1 cited
Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes
Blood·2025· 5 citedOpen Access
Neoantigenic properties of <i>TP53</i> variants modify cancer risk in individuals with Li-Fraumeni syndrome
2025Open Access
Optimized protocol for direct extraction of SARS-CoV-2 RNA from raw wastewater samples (ANRS 0160)
MethodsX·2025· 2 citedOpen Access
Parental germline mosaicism in genome-wide phased de novo variants: Recurrence risk assessment and implications for precision genetic counselling
PLoS Genetics·2025· 1 citedOpen Access
C-terminal binding protein-2 triggers CYR61-induced metastatic dissemination of osteosarcoma in a non-hypoxic microenvironment
Journal of Experimental & Clinical Cancer Research·2025· 5 citedOpen Access
Genome sequences of four Ixodes species expands understanding of tick evolution
BMC Biology·2025· 17 citedOpen Access
Development and Validation of a Next-Generation Sequencing-Based Method for Calculating the Breast Cancer Polygenic Risk Score Prs313
SSRN Electronic Journal·2025Open Access
SURFBAT: a surrogate family based association test building on large imputation reference panels
G3 Genes Genomes Genetics·2024· 3 citedOpen Access
Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Anne Boland(25), Jean‐François Deleuze(21), David Wallon(9), Gaël Nicolas(9), Benjamin Grenier‐Boley(8), Céline Bellenguez(8), Florence Pasquier(8), Didier Hannequin(7), Thierry Frébourg(7), Olivier Quenez(6), Adeline Rollin‐Sillaire(6), Philippe Amouyel(6), Céline Baulard(5), Marta Gut(5), Camille Charbonnier(5), Kilan Le Guennec(5), Guillaume Bourque(5), Hans Markus Münter(5), Vincent Meyer(5), Jean‐Charles Lambert(5)